The Business Times

Tokyo: Nikkei opens higher on massive US stimulus

Published Fri, Apr 10, 2020 · 12:43 AM
Share this article.

[TOKYO] Tokyo's key Nikkei index opened higher on Friday, extending rallies on Wall Street after the US Federal Reserve unveiled massive new stimulus.

The Nikkei 225 index was up 0.5 per cent, or 96.92 points, at 19,442.69 in early trade, while the broader Topix index slipped 0.2 per cent, or 3.22 points, to 1,413.76.

"Japanese shares are seen rising, encouraged by rallies in US shares... after the Fed's announcement of emergency stimulus," Toshiyuki Kanayama, senior market analyst at Monex, said in a note.

"The focus is whether the Nikkei index will be able to recover the 19,500 level" considered psychologically important, he added.

The dollar fetched 108.51 yen in early Asian trade, against 198.47 yen in New York.

Mutsumi Kagawa, chief global strategist at Rakuten Securities, said the market remains in a state of "tug-of-war between those who are pessimistic (about the virus pandemic) and those who are optimistic,... who think they don't want to miss a rare chance to buy" shares at cheap prices.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

In Tokyo, Uniqlo casual wear operator Fast Retailing rallied 5.49 per cent to 49,530 despite its announcement revising down profit forecast for the year to August.

Other major shares were mixed, with Toyota slipping 0.8 per cent to 6,630 yen and chip-making equipment manufacturer Tokyo Electron trading down 0.3 per cent at 22,875 yen, while parts maker Shin-Etsu Chemical was trading up 2 per cent at 11,475 yen.

On Wall Street, the Dow finished up 1.2 per cent at 23,719.37.

AFP

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Capital Markets & Currencies

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here